Galderma Group AG (GDERF)
Galderma Group Market Cap : 47.09B for Feb. 11, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Roche Holding AG | 368.15B |
| EvoNext Holdings SA | 7.933M |
| Kuros Biosciences Ltd. | 1.253B |
| Basilea Pharmaceutica AG | 871.16M |
Market Cap Related Metrics
| PS Ratio | 10.24 |
| PEG Ratio | 0.0135 |
| Price to Free Cash Flow | 65.14 |
| Price | 200.55 |
| Earnings Yield | 0.79% |
| PEGY Ratio | 0.0135 |
| Operating PE Ratio | 65.77 |
| Normalized PE Ratio | 114.10 |